[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:colony-stimulating-factor-receptor":3},{"name":4,"total":5,"recruiting":5,"trials":6},"Colony Stimulating Factor Receptor",2,[7,15],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT05828069","A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell Histiocytosis",[11],"Phase 2","RECRUITING","2026-08-26T02:16:16.995720Z","2026-05-05T02:43:29.729634Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT06600178","Study Targeting Myocardial Perfusion and Symptom Relief in Women With SGLT2 Inhibitors (STRONG)",[19],"Phase 1","2026-08-26T02:16:56.877406Z","2026-05-05T02:43:29.538984Z"]